{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:34:53Z","timestamp":1788194093158,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijmmb.2025.100788","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:36:44Z","timestamp":1736311004000},"page":"100788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In vitro efficacy of levonadifloxacin against methicillin-resistant Staphylococcus aureus (MRSA) including hVISA isolates collected across India"],"prefix":"10.1016","volume":"53","author":[{"given":"Sneha","family":"Vinayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4286-6908","authenticated-orcid":false,"given":"Sujatha","family":"Sistla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meerabai","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6845-1025","authenticated-orcid":false,"given":"Madhan","family":"Sugumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2025.100788_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fcimb.2014.00178","article-title":"Staphylococcus aureus biofilms: recent developments in biofilm dispersal","volume":"4","author":"Lister","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijmmb.2025.100788_bib2","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1073\/pnas.0402521101","article-title":"Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance","volume":"101","author":"Holden","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijmmb.2025.100788_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0255-0857.148837","article-title":"Vancomycin MIC creep in methicillin-resistant Staphylococcus aureus (MRSA) isolates from 2006 to 2010 in a hospital in China","volume":"33","author":"Chang","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2025.100788_bib4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/AAC.01536-10","article-title":"Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2025.100788_bib5","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.2147\/DDDT.S229882","article-title":"Levonadifloxacin, a novel broad-spectrum anti-MRSA benzoquinolizine quinolone agent: review of current evidence","volume":"13","author":"Bhagwat","year":"2019","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.ijmmb.2025.100788_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02272-14","article-title":"Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease","volume":"6","author":"Jenkins","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.ijmmb.2025.100788_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkz493","article-title":"In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016\u201318","volume":"75","author":"Appalaraju","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijmmb.2025.100788_bib8","first-page":"2156","article-title":"Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital","volume":"75","author":"Bakthavatchalam","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2025.100788_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4103\/ijmm.IJMM_20_307","article-title":"Assessment of antibacterial activity of levonadifloxacin against contemporary gram-positive clinical isolates collected from various Indian hospitals using disk-diffusion assay","volume":"38","author":"Baliga","year":"2020","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2025.100788_bib10","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"10.1016\/j.ijmmb.2025.100788_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00020-18","article-title":"Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology","volume":"31","author":"Lakhundi","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijmmb.2025.100788_bib12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1991.00400050040010","article-title":"Mechanisms of bacterial resistance to antibiotics","volume":"151","author":"Dever","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijmmb.2025.100788_bib13","first-page":"317","article-title":"Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections","volume":"9","author":"Parodi","year":"2003","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.ijmmb.2025.100788_bib14","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1099\/jmm.0.001102","article-title":"Levonadifloxacin (WCK 771) exerts potent intracellular activity against Staphylococcus aureus in THP-1 monocytes at clinically relevant concentrations","volume":"68","author":"Dubois","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2025.100788_bib15","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1021\/jm050035f","article-title":"A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus a ureus","volume":"48","author":"de Souza","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijmmb.2025.100788_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijmmb.2022.11.005","article-title":"India-discovered levonadifloxacin & alalevonadifloxacin: a review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care","volume":"41","author":"Veeraraghavan","year":"2023","journal-title":"Indian J Med Microbiol"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085725000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085725000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T19:12:24Z","timestamp":1742757144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085725000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":16,"alternative-id":["S0255085725000015"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100788","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro efficacy of levonadifloxacin against methicillin-resistant Staphylococcus aureus (MRSA) including hVISA isolates collected across India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100788"}}